Skip to main content
Premium Trial:

Request an Annual Quote

CellAura to Provide Regents for Cisbio Assays

NEW YORK (GenomeWeb News) – CellAura will provide its fluorescent reagents to Cisbio Bioassays for use with its non-radioactive assays for cellular studies, CellAura said today.

Under the agreement, CellAura will develop a number of reagents for Cisbio's Tag-lite platform, which is used for studies of cell surface receptor dimerization and ligand binding.

CellAura, a spin-out from the University of Nottingham, will retain the rights for the reagents developed for use in its own range of assays for certain markets.

Financial terms of the agreement were not released.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.